Literature DB >> 12912880

Worsening of steatosis and fibrosis progression.

V Ratziu, M Saboury, T Poynard.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12912880      PMCID： PMC1773788          DOI： 10.1136/gut.52.9.1386

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

Authors:  M Yuan; N Konstantopoulos; J Lee; L Hansen; Z W Li; M Karin; S E Shoelson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

2.  Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts.

Authors:  H Fehrenbach; R Weiskirchen; M Kasper; A M Gressner
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

3.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Authors:  J M Petit; J B Bour; C Galland-Jos; A Minello; B Verges; M Guiguet; J M Brun; P Hillon
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

4.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

5.  Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Authors:  Thierry Poynard; Vlad Ratziu; John McHutchison; Michael Manns; Zachary Goodman; Stefan Zeuzem; Zobair Younossi; Janice Albrecht
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

6.  Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.

Authors:  Alexander Monto; Judy Alonzo; Jessica J Watson; Carl Grunfeld; Teresa L Wright
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

7.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425
  7 in total
  3 in total

1.  Worsening of steatosis and fibrosis progression in hepatitis C.

Authors:  L Castéra; J-M Pawlotsky; D Dhumeaux
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 2.  Fat, diabetes, and liver injury in chronic hepatitis C.

Authors:  Vlad Ratziu; Jean-Baptiste Trabut; Thierry Poynard
Journal:  Curr Gastroenterol Rep       Date:  2004-02

3.  Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

Authors:  Ahmad Fouad; Dina Sabry; Rasha Ahmed; Manal Kamal; Sayed Abd Allah; Samar Marzouk; Mona Amin; Rokaya Abd El Aziz; Ahmad El Badri; Hany Khattab; Dina Helmy
Journal:  Int J Gen Med       Date:  2013-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.